To view this content, you need to sign in.
You should only be asked to sign in once. Not the case? Click here
Register now to access this content and more for free.
Shackleton buys NESTA stake in healthcare company
Shackleton Ventures has deviated from its typical direct secondaries strategy, making a follow-on investment into medical technology company Nanosight. It purchased the stake from UK government-backed NESTA, which hopes the deal will set a precedent for early stage secondaries investments.
